Arrhythmias and ECG changes in life threatening hyperkalemia in older patients treated by potassium sparing drugs

被引:6
作者
Berkova, Marie [1 ]
Berka, Zdenek [2 ]
Topinkova, Eva [1 ]
机构
[1] Charles Univ Prague, Fac Med 1, Dept Geriatr, Prague, Czech Republic
[2] Univ Hosp Olomouc, Dept Internal Med Gastroenterol & Hepatol 2, Olomouc, Czech Republic
来源
BIOMEDICAL PAPERS-OLOMOUC | 2014年 / 158卷 / 01期
关键词
hyperkalemia; electrocardiogram; potassium sparing drugs; elderly patients; CHRONIC HEART-FAILURE; MANAGEMENT; ATRIAL;
D O I
10.5507/bp.2012.087
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background. Severe hyperkalemia is a life threatening condition that can cause fatal rhythm disturbance and terminal heart arrest. The most common cause of hyperkalemia in older patients is that of iatrogenic medication-related etiology due to associated polymorbidity, polypharmacy and reduced reserve metabolic capacity. The aim of this paper is to increase awareness in the clinicians of the risk of hyperkalemia in elderly patients treated by potassium sparing drugs. Methods and Results. We present two case reports of hyperkalemia >= 9.0 mmol/L induced by potassium sparing medications with cardiac arrhythmias and severe ECG changes including atrial asystole, disturbance of intraventricular conduction and morphological changes such as tenting T waves and deformed wide QRS complexes. The most frequent causes of hyperkalemia in elderly patients are discussed and electrocardiogram changes and arrhythmias in hyperkalemia are analyzed, as well as their treatment and prevention. Conclusion. Potassium sparing drug therapy in older persons requires more frequent monitoring especially when drugs or their doses are changed, or during concomitant acute illness.
引用
收藏
页码:84 / 91
页数:8
相关论文
共 49 条
[1]  
[Anonymous], 2005, Circulation, V112, pIV1, DOI DOI 10.1161/CIRCULATIONAHA.105.166550
[2]  
BAROLD SS, 1987, J AM COLL CARDIOL, V10, P467
[3]   Hypokalemia and Outcomes in Patients With Chronic Heart Failure and Chronic Kidney Disease Findings From Propensity-Matched Studies [J].
Bowling, C. Barrett ;
Pitt, Bertram ;
Ahmed, Mustafa I. ;
Aban, Inmaculada B. ;
Sanders, Paul W. ;
Mujib, Marjan ;
Campbell, Ruth C. ;
Love, Thomas E. ;
Aronow, Wilbert S. ;
Allman, Richard M. ;
Bakris, George L. ;
Ahmed, Ali .
CIRCULATION-HEART FAILURE, 2010, 3 (02) :253-260
[4]   Complications of inappropriate use of spiroholactone in heart failure: When an old medicine spirals out of new guidelines [J].
Bozkurt, B ;
Agoston, I ;
Knowlton, AA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (02) :211-214
[5]   Management of severe hyperkalemia without hemodialysis: Case report and literature review [J].
Carvathana, Virginia ;
PharmD, Lisa Burry ;
Lapinsky, Stephen E. .
JOURNAL OF CRITICAL CARE, 2006, 21 (04) :316-321
[6]   Association of Aldosterone Concentration and Mineralocorticoid Receptor Genotype with Potassium Response to Spironolactone in Patients with Heart Failure [J].
Cavallari, Larisa H. ;
Groo, Vicki L. ;
Viana, Marlos A. G. ;
Dai, Yang ;
Patel, Shitalben R. ;
Stamos, Thomas D. .
PHARMACOTHERAPY, 2010, 30 (01) :1-9
[7]  
Chakraborty B, 2006, ORION MED J, V25, P411
[8]  
Chardos J, 2008, MAYO CLIN PROC, V83, P368, DOI 10.4065/83.3.368
[9]  
Dimmitt SB, 2009, BRIT MED J, V339, DOI [10.1136/bmj.b4114, DOI 10.1136/BMJ.B4114]
[10]   The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease [J].
Einhorn, Lisa M. ;
Zhan, Min ;
Hsu, Van Doren ;
Walker, Lori D. ;
Moen, Maureen F. ;
Seliger, Stephen L. ;
Weir, Matthew R. ;
Fink, Jeffrey C. .
ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (12) :1156-1162